Media: India's Ajanta Pharma under scanner for marketing unapproved drugs - Mint
- Source link: https://bit.ly/2LgT69f
- Note: Reuters has not verified this story and does not
vouch for its accuracy
(Bengaluru newsroom)
((ReutersIndia.snapping@thomsonreuters.com; +91 80 6749 1310;))
Recent news on Ajanta Pharma
See all newsIndia's Ajanta Pharma falls as analysts say growth to moderate in H2
Brief: Ajanta Pharma Limited Sept-Quarter Consol Net Profit 3.88 Billion Rupees
India's Ajanta Pharma jumps on June quarter profit jump
Brief: Ajanta Pharma June-Quarter Consol PAT 3.34 Billion Rupees
Brief: Ajanta Pharma Receives US FDA Establishment Inspection Report For Paithan Facility